Effect of Silver Diamine Fluoride on Local Anesthesia in Hypomineralized Molars

Anesthesia, Local Clinical Trial

Official title:

Effect of Silver Diamine Fluoride on Local Anesthesia Efficacy in Molar Incisor Hypomineralization-affected Molars in Children: A Randomized Clinical Trial

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT05964387
• Other study ID #: HUM00228059
• Status: Recruiting
• Phase: N/A
• Start date: June 12, 2023
• Est. completion date: July 1, 2024

Study information

• Verified date: July 2023
• Source: University of Michigan
• Contact: James Boynton, DDS
• Phone: 734-763-2331
• Email: jboynton[@]umich.edu
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The purpose of this randomized, controlled clinical study is to evaluate if application of 38% SDF increases the efficacy of local anesthesia during operative dentistry on permanent molars affected by molar-incisor hypoplasia (MIH). The goal is to determine if pre-operative application of SDF results in improved local anesthesia and decrease in procedural pain in MIH affected teeth, thereby addressing an important challenge in routine clinical practice and contributing to the development of a treatment protocol for MIH affected molars.

Description:

Molar incisor hypomineralization (MIH) is defined as a qualitative enamel defect of unknown etiology that affects one or more permanent molars and may also affect the permanent incisors. Clinically, the presentation of MIH depends on severity: lesions can range from mild, with white to yellow-brown discolored opacities, to severe, with extensive post-eruptive enamel breakdown and atypical caries. Hypomineralized enamel has increased porosity with reduced mineral content, which promotes bacteria penetration, resulting in development and rapid progression of dental caries and subclinical chronic pulp inflammation. Treatment of teeth affected by MIH pose a clinical challenge due to several reasons. Post-eruptive breakdown of inadequately formed enamel exposes underlying dentin, resulting in hypersensitivity to hot and cold temperatures, air, and water. This increased tooth sensitivity leads to poor oral hygiene and subsequent plaque retention. Additionally, chronic subclinical inflammation of the pulp hypersensitizes the gamma-aminobutyric acid (GABA) receptors in the pulp nerve tissue and reduces the pain threshold in these teeth. This weakens the action of local anesthetics making it difficult to achieve adequate pain control during dental treatment. Recently, 38% silver diamine fluoride (SDF), a solution of silver fluoride and ammonium ions, has been shown to be effective in tooth desensitization by blocking dentinal tubules and promoting remineralization of demineralized tooth structure. SDF can be useful in managing symptomatic MIH-affected teeth by stimulating the production of calcium fluoride and silver iodide, both of which are able to occlude dentinal tubules and reduce their patency. The purpose of this randomized, controlled clinical study is to evaluate the efficacy of local anesthesia on MIH-affected molars treated with 38% SDF. The goal is to determine if pre-operative application of SDF results in improved local anesthesia and decrease in procedural pain in MIH affected teeth, thereby addressing an important challenge in routine clinical practice and contributing to the development of a treatment protocol for MIH affected molars.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 50
• Est. completion date: July 1, 2024
• Est. primary completion date: July 1, 2024
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 6 Years to 11 Years

Eligibility

Inclusion Criteria:

• At least one hypomineralized first permanent molar with a primary cavitated caries lesion(s) or a cavitated tooth defect requiring restorative dental care with local anesthesia
• American Society of Anesthesiologists (ASA) Physical Status Classification I or II (healthy children or those with mild systemic disease)
• English speaking
• Subjects for which basic behavior guidance (non-pharmacological or nitrous oxide/oxygen) is indicated

Exclusion Criteria:

• Teeth with irreversible pulpitis and pulp necrosis
• Patients requiring advanced behavior management such as moderate sedation, general anesthesia, and/or active or passive restraint
• Inability of the child to cooperate due to special needs or other conditions
• Allergy to SDF, local anesthetic or other material component
• Subjects with ulcerative gingivitis or stomatitis
• Subjects with known sensitivity to silver or other heavy-metal ions
• Subjects showing abnormal skin sensitization in daily circumstances

Related Conditions & MeSH terms

• Anesthesia, Local
• Dental Enamel Hypoplasia
• Molar Incisor Hypomineralization

Intervention

Device:
• SDF
38% SDF will be applied to the hypoplastic area of the enrolled first permanent molar.
• Placebo
An inert liquid will be applied to the hypoplastic area of the enrolled first permanent molar.

Locations

Country	Name	City	State
United States	University of Michigan	Ann Arbor	Michigan

Sponsors (1)

Lead Sponsor	Collaborator
University of Michigan

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Other	Face, Legs, Activity, Cry, Consolability (FLACC) Scale	Three point scale evaluating five components of behavior and expression of discomfort in children	At least two weeks following application of SDF or placebo on the enrolled tooth
Primary	Sixou and Barbosa-Rogier scale for local anesthesia efficacy	Four point scale evaluating efficacy of local anesthesia	At least two weeks following application of SDF or placebo on the enrolled tooth
Secondary	Schiff Cold Air Sensitivity Scale	Four point scale evaluating tooth sensitivity to cold	At least two weeks following application of SDF or placebo on the enrolled tooth